Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Specimen Handling 123Magnetic Resonance Spectroscopy 99Biopsy 72pembrolizumab 58Carboplatin 55Nivolumab 54Cisplatin 53Cyclophosphamide 51Paclitaxel 41Bevacizumab 36Radiotherapy 33Gemcitabine 33Dexamethasone 30Doxorubicin 25atezolizumab 24Fluorouracil 24olaparib 23Rituximab 23Pemetrexed 23fludarabine 22durvalumab 21Radiation 21Cytarabine 21venetoclax 20Vincristine 20Prednisone 20Oxaliplatin 20Ipilimumab 20Injections 20Lenalidomide 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Spermine Synthase × 30 days × Clear all
NCT07234877 2026-06-04

Phase II Study of Upfront SRT Plus Ivonescimab/Chemotherapy vs Ivonescimab/Chemotherapy in NSCLC Brain Mets

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Not yet recruiting
158 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡